Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 9, 2026

7 hours ago

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027

Indeterminate GlobeNewswire

7 hours ago

Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

Indeterminate GlobeNewswire

7 hours ago

Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure

Indeterminate GlobeNewswire

7 hours ago

ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders

Indeterminate GlobeNewswire

7 hours ago

IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

Indeterminate GlobeNewswire

8 hours ago

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

8 hours ago

Monogram Health Publishes Inaugural Impact Report, Documenting Impressive Clinical and Financial Outcomes Resulting From Its In-Home Multispecialty Medical Group Care Model

Indeterminate GlobeNewswire

8 hours ago

Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial

Indeterminate GlobeNewswire

8 hours ago

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Indeterminate GlobeNewswire

8 hours ago

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

8 hours ago

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Indeterminate GlobeNewswire

8 hours ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

8 hours ago

IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Indeterminate GlobeNewswire

8 hours ago

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Indeterminate GlobeNewswire

8 hours ago

Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo

Indeterminate GlobeNewswire

8 hours ago

NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program

Indeterminate GlobeNewswire

8 hours ago

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

Indeterminate GlobeNewswire

8 hours ago

Aktis Oncology to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Indeterminate GlobeNewswire

8 hours ago

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire